Oportun Financial Corp
OPRT Nasdaq Finance Services Financials FY2017βFY2025
What Oportun Financial Corp does
No business description yet.
- Legal name
- Oportun Financial Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001538716-26-000015
0001538716
Revenue and margins
Oportun Financial Corp had $957M of revenue in fiscal 2025, down 4.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Oportun Financial Corp returned β to shareholders in fiscal 2025. The diluted share count rose 18.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Oportun Financial Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $131M | $98.8M | $91.2M | $60.0M | $106M |
| Debt incl. finance leases | $114M | β | β | β | β |
| Debt / equity | 0.2x | β | β | β | β |
| Total assets | $2.9B | $3.6B | $3.4B | $3.2B | $3.3B |
| Total liabilities | $2.3B | $3.1B | $3.0B | $2.9B | $2.9B |
| Shareholders' equity | $604M | $548M | $404M | $354M | $390M |
| Net debt (β = net cash) | β$16.9M | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β | β0.9% | β8.0% | β9.4% | β4.7% | β9.9% | β16.3% | β14.2% | β12.0% |
| Altman Z'' | β | β | β | β | β | β | β | β | β |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $361M | $498M | $600M | $584M | $627M | $953M | $1.1B | $1.0B | $957M |
| Noninterest expense | $224M | $287M | $362M | $393M | $468M | $716M | β | β | β |
| Provision for credit losses | $98.3M | $16.1M | β$4.5M | $0.0M | β | β | β | β | β |
| Pretax income | $2.1M | $170M | $84.4M | β$58.1M | $62.8M | β$75.3M | β$254M | β$115M | $44.1M |
| Income tax | $12.3M | $46.7M | $22.8M | β$13.0M | $15.4M | $2.5M | β$73.7M | β$36.5M | $18.8M |
| Net income | β$10.2M | $123M | $61.6M | β$45.1M | $47.4M | β$77.7M | β$180M | β$78.7M | $25.2M |
| Net income to common | β$10.2M | $16.6M | $4.3M | β$45.1M | $47.4M | β$77.7M | β$180M | β$78.7M | $25.2M |
| Diluted EPS | β$4.22 | $4.47 | $0.40 | β$1.65 | $1.56 | β$2.37 | β$4.88 | β$1.95 | $0.53 |
| Diluted shares | 0.00B | 0.00B | 0.01B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.05B |
| Cash flow | |||||||||
| Cash from operations | $139M | $138M | $218M | $153M | $163M | $248M | $393M | $394M | $413M |
| Capital expenditure | $8.5M | $14.6M | $8.9M | $4.8M | $12.3M | $6.0M | β | β | β |
| Free cash flow | $131M | $124M | $209M | $148M | $151M | $242M | β | β | β |
| Depreciation and amortization | $10.6M | $11.8M | $14.1M | $20.2M | $27.1M | $47.5M | $54.9M | $51.2M | $41.4M |
| Stock-based compensation | $5.7M | $6.8M | $19.2M | $19.5M | $18.9M | $27.6M | $18.6M | $13.0M | $10.7M |
| Acquisitions | β | β | β | $0.0M | $112M | $0.0M | β | β | β |
| Balance sheet | |||||||||
| Cash and short-term investments | $48.3M | $70.5M | $72.2M | $136M | $131M | $98.8M | $91.2M | $60.0M | $106M |
| Total debt | β | β | β | β | $114M | β | β | β | β |
| Loans, net | β | $296M | $38.5M | $0.0M | β | β | β | β | β |
| Property and equipment, net | β | $23.2M | $22.8M | $15.9M | $9.9M | $10.5M | $7.0M | $3.0M | $2.1M |
| Goodwill | β | β | β | $0.0M | $104M | $0.0M | β | β | β |
| Intangible assets | β | β | β | $0.1M | $43.6M | $35.7M | $27.5M | $19.9M | $71.7M |
| Total assets | β | $1.7B | $2.2B | $2.0B | $2.9B | $3.6B | $3.4B | $3.2B | $3.3B |
| Total liabilities | β | $1.4B | $1.7B | $1.5B | $2.3B | $3.1B | $3.0B | $2.9B | $2.9B |
| Preferred stock | β | $0.0M | $0.0M | β | β | β | β | β | β |
| Shareholders' equity | $217M | $347M | $489M | $467M | $604M | $548M | $404M | $354M | $390M |
| Margins | |||||||||
| Net margin | β2.8% | 24.8% | 10.3% | β7.7% | 7.6% | β8.2% | β17.0% | β7.9% | 2.6% |
| FCF margin | 36.2% | 24.9% | 34.9% | 25.4% | 24.1% | 25.4% | β | β | β |
| Efficiency ratio | 62.1% | 57.7% | 60.4% | 67.4% | 74.6% | 75.2% | β | β | β |
| Returns | |||||||||
| Return on equity | β4.7% | 43.8% | 14.7% | β9.4% | 8.9% | β13.5% | β37.8% | β20.8% | 6.8% |
| Return on assets | β | 7.1% | 3.1% | β2.1% | 1.9% | β2.4% | β5.1% | β2.4% | 0.8% |
| Return on tangible equity | β4.7% | 4.8% | 0.9% | β9.7% | 10.4% | β15.2% | β47.7% | β23.6% | 7.9% |
| Growth | |||||||||
| Revenue growth | β | 37.9% | 20.6% | β2.7% | 7.4% | 52.0% | 11.0% | β5.2% | β4.5% |
| Net income growth | β | β | β50.1% | β173.2% | β | β264.0% | β | β | β |
| EPS growth | β | β | β91.1% | β512.5% | β | β251.9% | β | β | β |
| FCF growth | β | β5.2% | 69.2% | β29.3% | 2.1% | 60.0% | β | β | β |
| Share count change | β | 53.5% | 189.7% | 154.0% | 10.9% | 8.3% | 12.3% | 9.4% | 18.6% |
| Financial health | |||||||||
| Debt / equity | β | β | β | β | 0.2x | β | β | β | β |
| Provision / loans | β | 5.5% | β11.7% | β | β | β | β | β | β |
| Capital allocation | |||||||||
| Capex / revenue | 2.4% | 2.9% | 1.5% | 0.8% | 2.0% | 0.6% | β | β | β |
| Stock comp / revenue | 1.6% | 1.4% | 3.2% | 3.3% | 3.0% | 2.9% | 1.8% | 1.3% | 1.1% |
| Quality scores | |||||||||
| Accruals ratio | β | β0.9% | β8.0% | β9.4% | β4.7% | β9.9% | β16.3% | β14.2% | β12.0% |
Source: SEC EDGAR XBRL filings (CIK 0001538716). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.